Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Pancreatic Neoplasms 18Prostatic Neoplasms 11Carcinoma, Hepatocellular 8Liver Neoplasms 7Neoplasm Metastasis 3Melanoma 3Lung Neoplasms 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Unresectable Pancreatic Cancer 2Stomach Neoplasms 2Squamous Intraepithelial Lesions 2Neoplasms 2Lymphatic Metastasis 2Locally Advanced Pancreatic Cancer 2Kidney Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma Resectable 1

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 136Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 68fludarabine phosphate 62Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Specimen Handling 36Cisplatin 36CTLA-4 Antigen 36Magnetic Resonance Spectroscopy 35Carboplatin 35cobimetinib 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Melanoma × Electroporation × Clear all
NCT04526730 2026-02-20

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
17 enrolled 11 charts
Dermatologic

Melanoma, Skin Neoplasms

NCT01045915 2015-09-11

AMEP

Valerio Therapeutics

Phase 1 Terminated
5 enrolled
Dermatologic

Melanoma

NCT01764009 2015-09-11

AIMM

Valerio Therapeutics

Phase 1/2 Withdrawn
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡